Truist Financial analyst David S Macdonald maintained a Buy rating on CVS Health (CVS – Research Report) today. The company’s shares closed ...

CVS Health (CVS) is a top S&P 500 performer in 2025, with year-to-date returns exceeding 50%. Moreover, the stock has shirked ...